000 | 01292 a2200325 4500 | ||
---|---|---|---|
005 | 20250514045328.0 | ||
264 | 0 | _c20021108 | |
008 | 200211s 0 0 eng d | ||
022 | _a0732-183X | ||
024 | 7 |
_a10.1200/JCO.2002.99.158 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWölfler, Albert | |
245 | 0 | 0 |
_aQuestionable benefit of melatonin for antioxidant pharmacologic therapy. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cOct 2002 |
||
300 |
_a4127-8; author reply 4128-9 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMelatonin _xpharmacology |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
700 | 1 | _aAbuja, Peter M | |
700 | 1 | _aLinkesch, Werner | |
700 | 1 | _aSchauenstein, Konrad | |
700 | 1 | _aLiebmann, Peter M | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 20 _gno. 19 _gp. 4127-8; author reply 4128-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2002.99.158 _zAvailable from publisher's website |
999 |
_c12164287 _d12164287 |